What is the address of DEMONCEAU - NEUROPEDI?

The registered office of DEMONCEAU - NEUROPEDI is located at Sur le Tombeux 35, 4821 Dison.

Is DEMONCEAU - NEUROPEDI still active?

Yes. According to the CBE (31 October 2026) DEMONCEAU - NEUROPEDI is active, legal situation “Normale toestand”, started on 1 July 2011.

Is DEMONCEAU - NEUROPEDI registered on Peppol?

Yes, DEMONCEAU - NEUROPEDI is registered on the Peppol network with ID 0208:0837497604.

What is the enterprise number of DEMONCEAU - NEUROPEDI?

The enterprise number of DEMONCEAU - NEUROPEDI is BE0837497604.

When was DEMONCEAU - NEUROPEDI founded?

DEMONCEAU - NEUROPEDI was founded on 1 July 2011.

Who are the directors of DEMONCEAU - NEUROPEDI?

According to the 2025 annual accounts, the directors of DEMONCEAU - NEUROPEDI are: Nathalie DEMONCEAU.

Is DEMONCEAU - NEUROPEDI a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 1 July 2011; 5 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did DEMONCEAU - NEUROPEDI make in 2025?

DEMONCEAU - NEUROPEDI posted a profit after taxes of € 35,438 in financial year 2025.

What is the revenue of DEMONCEAU - NEUROPEDI?

As a small company, DEMONCEAU - NEUROPEDI is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 72,292.

DEMONCEAU - NEUROPEDI (Private Limited) - Dison

Dossier DEMONCEAU - NEUROPEDI, printed on 31 October 2026 from databakkes.be/en/0837497604/demonceau-neuropedi. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

Tight liquidity NBB

Cash and receivables cover 43 % of short-term debt in 2025; threshold 65 %.

Financials

Financial year 2025

DEMONCEAU - NEUROPEDI from Dison, company number BE0837497604, closed financial year 2025 with a result of € 35,438 after tax. For that financial year DEMONCEAU - NEUROPEDI recorded a gross margin of € 72,292 and equity of € 206,026. Compared with financial year 2024, the result moved from € 32,587 to € 35,438. Profitable, and profit is growing. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on July 15, 2026.

What it is worth Healthy

€ 206,026

▼ 9% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 35,438

▲ 9% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 119,250

▼ 75% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 54,657 paid out

More than the year’s profit went to the shareholders; reserves fell.

People and assets in 2025

Vehicles and equipment

€ 2,748

▼ 66% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt

None

No bank loans on the last day of the fiscal year.

Taxes and wages

€ 8,195

▲ 277% vs 2024

Taxes, VAT and social contributions still to pay.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 54,352 Gross margin 2022: € 54,352 First fiscal year in the series	€ 58,552 Gross margin 2023: € 58,552 ▲ 8% vs 2022 (€ 54,352) Favourable step	€ 65,163 Gross margin 2024: € 65,163 ▲ 11% vs 2023 (€ 58,552) Favourable step	€ 72,292 Gross margin 2025: € 72,292 ▲ 11% vs 2024 (€ 65,163) Favourable step	▲ 11%
Profit after taxes	€ 28,503 Profit after taxes 2022: € 28,503 First fiscal year in the series	€ 30,238 Profit after taxes 2023: € 30,238 ▲ 6% vs 2022 (€ 28,503) Favourable step	€ 32,587 Profit after taxes 2024: € 32,587 ▲ 8% vs 2023 (€ 30,238) Favourable step	€ 35,438 Profit after taxes 2025: € 35,438 ▲ 9% vs 2024 (€ 32,587) Favourable step	▲ 9%
Equity	€ 242,735 Equity 2022: € 242,735 First fiscal year in the series	€ 192,659 Equity 2023: € 192,659 ▼ 21% vs 2022 (€ 242,735) Unfavourable step	€ 225,245 Equity 2024: € 225,245 ▲ 17% vs 2023 (€ 192,659) Favourable step	€ 206,026 Equity 2025: € 206,026 ▼ 9% vs 2024 (€ 225,245) Unfavourable step	▼ 9%
Total debts	€ 177,524 Total debts 2022: € 177,524 First fiscal year in the series	€ 261,608 Total debts 2023: € 261,608 ▲ 47% vs 2022 (€ 177,524) Unfavourable step	€ 276,356 Total debts 2024: € 276,356 ▲ 6% vs 2023 (€ 261,608) Unfavourable step	€ 296,039 Total debts 2025: € 296,039 ▲ 7% vs 2024 (€ 276,356) Unfavourable step	▲ 7%
Cash	€ 384,628 Cash 2022: € 384,628 First fiscal year in the series	€ 417,974 Cash 2023: € 417,974 ▲ 9% vs 2022 (€ 384,628) Favourable step	€ 471,984 Cash 2024: € 471,984 ▲ 13% vs 2023 (€ 417,974) Favourable step	€ 119,250 Cash 2025: € 119,250 ▼ 75% vs 2024 (€ 471,984) Unfavourable step	▼ 75%
Retained profit	€ 165,535 Retained profit 2022: € 165,535 First fiscal year in the series	€ 180,259 Retained profit 2023: € 180,259 ▲ 9% vs 2022 (€ 165,535) Favourable step	€ 212,845 Retained profit 2024: € 212,845 ▲ 18% vs 2023 (€ 180,259) Favourable step	€ 193,626 Retained profit 2025: € 193,626 ▼ 9% vs 2024 (€ 212,845) Unfavourable step	▼ 9%
Dividend	€ 79,000 Dividend 2022: € 79,000 First fiscal year in the series	€ 15,515 Dividend 2023: € 15,515 ▼ 80% vs 2022 (€ 79,000) Unchanged	€ 0 Dividend 2024: € 0 ▼ 100% vs 2023 (€ 15,515) Unchanged	€ 54,657 Dividend 2025: € 54,657 Unchanged (€ 0) Unchanged
Balance sheet total	€ 420,260 Balance sheet total 2022: € 420,260 First fiscal year in the series	€ 454,266 Balance sheet total 2023: € 454,266 ▲ 8% vs 2022 (€ 420,260) Unchanged	€ 501,602 Balance sheet total 2024: € 501,602 ▲ 10% vs 2023 (€ 454,266) Unchanged	€ 502,065 Balance sheet total 2025: € 502,065 Unchanged (€ 501,602) Unchanged

Key figures of DEMONCEAU - NEUROPEDI, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to DEMONCEAU - NEUROPEDI?

What happened at DEMONCEAU - NEUROPEDI in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Jul 15, 2026 New annual accounts for financial year 2025: profit of € 35,438 (▲ 9% vs 2024). Source: NBB ↗
2023 Nathalie DEMONCEAU became a director. NBB
Jul 11, 2011 New establishment in Dison. KBO
Jul 1, 2011 Start of the company according to the CBE. KBO

In short

From € 28,503 profit in 2022 to € 35,438 profit in 2025.

Paid € 54,973 in corporate taxes since 2022.

Best year ever: 2025, with € 35,438 profit.

Paid out € 149,171 in dividends to the owners in total.

Original PDFs at the National Bank ↗

Management

Nathalie DEMONCEAU

DEMONCEAU - NEUROPEDI

Behind DEMONCEAU - NEUROPEDI is Nathalie DEMONCEAU.

Directors

According to the 2025 annual accounts

Nathalie DEMONCEAU

Director

since 2023

Establishments

Establishment units

Physical locations of this company

Registered office

Sur le Tombeux 35

4821 Dison

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0837.497.604
VAT number: BE 0837.497.604
Registered office: Sur le Tombeux 35, 4821 Dison
Names & denominations: DEMONCEAU - NEUROPEDI
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 1 July 2011
Peppol: Active · Active since 7 Dec 2025

View on CBE Public ↗ Annual accounts (NBB) ↗